PPD Earns Awards for Excellence in Regulatory Affairs
WILMINGTON, N.C., (Nov. 30, 2017) – Pharmaceutical Product Development, LLC (PPD) today announced it earned two honors for excellence in regulatory affairs at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards in London.
PPD provides comprehensive regulatory services across the spectrum of global product development, registration and commercialization. With regulatory experience spanning all areas of pharmaceuticals, PPD’s global regulatory experts provide intelligence and strategic insight to optimize product success.
“PPD’s regulatory affairs teams are committed to the pursuit of excellence in providing regulatory intelligence for product development and registration strategies and ensuring high-quality submissions to regulatory authorities,” said William Sharbaugh, chief operating officer of PPD. “Congratulations to our employees for being recognized as industry leaders for their expertise and efforts to help our clients improve patient health.”
Evolus, Inc., a U.S.-based biotechnology company that utilizes PPD services, nominated the collaborative Evolus-PPD team for the TOPRA Award for Support, which recognizes the critical role supporting organizations play in drug development. PPD has provided Evolus an end-to-end service solution from the outset of early engagement consulting activities, including scientific advice through to clinical trial execution and the filing and management of global marketing applications (MA).
“The PPD team integrated seamlessly with our team, providing a global ‘one team’ solution to meet our corporate goals,” said Del Stagg, Ph.D., vice president, regulatory affairs of Evolus.
Clare Ryder, Ph.D., associate director of regulatory affairs of PPD, received the TOPRA Award in the Contribution category, which recognizes significant and consistent contributions to a team, project, regulatory science or the profession. Ryder, who also is a member of the Evolus-PPD team, was recognized for reliably meeting clients’ goals of submitting MAs within often tight timeframes.
TOPRA established its awards for regulatory excellence in 2010 to recognize the achievements of the regulatory affairs community. The winners are selected by an independent judging panel.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.